07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CYP450 epoxygenase and inward rectifier potassium channels to test whether these pathways,<br />

acting partly in parallel, could fully account <strong>for</strong> the blood flow response to neuronal activation.<br />

Cerebral blood flow (CBF) and oxygenation over the somatosensory cortex were measured<br />

during electrical <strong>for</strong>epaw stimulation in rats using a combined laser doppler/spectroscopy probe<br />

through a superfused cranial window. Somatosensory evoked potentials (SEP) were recorded as<br />

a correlate of neuronal activity. The CBF response was largely reduced with stable SEP during<br />

combined inhibition of NO synthase, cyclooxygenase, adenosine receptors and CYP450<br />

epoxygenase. Additional inhibition of inward rectifier potassium channels did not lead to a<br />

significant further reduction of the CBF response. Despite significant reduction of the CBF<br />

response, no deoxygenation could be detected. In summary, the NO, adenosine, cyclooxygenase,<br />

CYP450 epoxygenase and inward rectifier potassium channel pathways together account <strong>for</strong><br />

approximately two third of functional hyperemia in the rat somatosensory cortex. As yet<br />

unidentified additional pathways might be involved in coupling neuronal activity to regional<br />

cerebral blood flow. In rat somatosensory cortex, only one third of the blood flow increase is<br />

required to prevent relative hypoxia during increased neuronal activity.<br />

Disclosures: C. Leithner , None; G. Royl, None; N. Offenhauser, None; M. Füchtemeier,<br />

None; M. Kohl-Bareis, None; A. Villringer, None; U. Dirnagl, None; U. Lindauer, None.<br />

Poster<br />

286. Imaging the Nervous System<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 286.11/QQ51<br />

Topic: E.09.c. Blood brain barrier<br />

Support: DOD BC050006<br />

<strong>Title</strong>: Permeability measurements at the blood-brain and blood-tumor barrier using different<br />

molecular weight fluorescent markers<br />

Authors: *R. MITTAPALLI 1 , K. A. BOHN 2 , J. M. EGBERT 2 , V. K. MANDA 2 , V.<br />

RUDRARAJU 2 , K. S. TASKAR 2 , J. A. GAASCH 2 , Q. R. SMITH 2 , P. R. LOCKMAN 2 ;<br />

1 TTU HSC, Amarillo,, TX; 2 Pharmaceut. Sci., Texas Tech. Univ. HSC, Sch. of Pharm.,<br />

Amarillo, TX<br />

<strong>Abstract</strong>: Introduction: The unique anatomical structure of the brain neurovasculature limits<br />

chemotherapeutic distribution into normal brain and to a lesser extent, brain tumors. While there<br />

are documented vascular permeability differences between tumor and normal brain, less is<br />

known about permeability changes in various tumor regions. There<strong>for</strong>e, we developed a novel

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!